Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
18 Sep 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/carismas-lifeline-dissipates-reverse-merger-plans-fall-through-moderna-cuts-ties
15 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/15/3149790/0/en/Ocugen-Inc-and-Kwangdong-Pharmaceutical-Co-Ltd-Complete-License-Agreement-of-OCU400-Modifier-Gene-Therapy-for-Retinitis-Pigmentosa-in-Korea.html
02 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/02/3142506/0/en/Ocugen-to-Participate-in-H-C-Wainwright-27th-Annual-Global-Investment-Conference-Biotech-on-Tap-2025.html
13 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/13/3132400/0/en/Ocugen-Inc-Announces-Positive-Scientific-Advice-from-the-European-Medicines-Agency-Related-to-the-Approval-Pathway-for-OCU410ST-Modifier-Gene-Therapy-for-Stargardt-Disease.html
12 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/12/3132070/0/en/Ocugen-Inc-Announces-Closing-of-20-Million-Registered-Direct-Offering-of-Common-Stock-and-Warrants.html
08 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/08/3130420/0/en/Ocugen-Inc-Announces-20-Million-Registered-Direct-Offering-of-Common-Stock-and-Warrants.html
ABOUT THIS PAGE